+1,264.0%
QBTS vs THC
+413.3%
+850.7%
-79.8%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +18.0% | -1.1% | +19.1% | +18.2% |
| 7D | +0.3% | +3.7% | -3.4% | -0.2% |
| 30D | -29.8% | +9.0% | -38.9% | -30.7% |
| 3M | -45.0% | +10.4% | -55.4% | -45.8% |
| 6M | -55.2% | +45.7% | -100.8% | -58.0% |
| YTD | -59.2% | +42.6% | -101.7% | -61.7% |
| 1Y | -62.4% | +38.8% | -101.1% | -64.5% |
| 3Y | +1,264.0% | +418.8% | +845.2% | +644.2% |
| All | +1,264.0% | +413.3% | +850.7% | +644.2% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling